INTRGDUCTION
Butyrylcholinesterase (pseudocholinesterase; acylcho-line acylhydrolase: EC 3.1.1.8) is present in various human tissues as well as in plasma and in other biological fluids. So far, no physiological function has been assigned to this enzyme but it is of pharmacological and toxicological importance because it is involved in the metabolism of ester containing drugs [I] and because it is inhibited by organophosphates and carbamates like the related enzyme acetylcholinesterase
121.
The plasma BChE shows a complex molecular polymorphism.
Numerous molecular forms can be detected by gel electrophoresis. Four main forms named Cl, CZ, Cp and C4 according to their electrophoretic mobility have long been identified [3] . Cl, C3 and C4 are monomer, dimer and tetramer, respectively [4, 5] . The Ct component is a BChE monomer-albu~n conjugate [6] , Other components are often observed depending on storage [3], partial proteolysis [7] and/or electrophoresis conditions [8] , one [9] ; this gene has been presumed to direct the production of an additional plasma form called CS because it is a slow-migrating component. This form is present in 8-10% of Caucasians but is found with lower frequency in most other populations [l] . Individuals carrying the CS form have an elevated plasma BChE activity (up to 30% higher than normal level). The CS variant appears to be a hybrid enzyme composed of BChE subunits coded by the El gene [9] associated with another protein whose nature is still unknown [lo] . Other slow-migrating variants have been reported [l] ; some of them have been observed in malignant diseases [ 11,121, but little is known about these forms, and their relationship with CS is uncertain.
Two genetic loci, El and E2 (designated CHEl and CHE2 before 1990, and renamed BChE and CHE2 in 1990 by the Human Gene Nomenclature Com~ttee), directing the production of plasma BChE have been identified from genetic population studies. The E1 locus shows a high polyallelism [l] ; it encodes for the 'normal' enzyme which exhibits the above-mentioned molecular forms. The Ez locus is not allelic to the first [16] found a tight linkage between the y-crystallin gene cluster (CRYG) on chromosome 2 and CS (CHE2), reporting a highly significant lod score of 4.21 at a recombination distance of 0.00. It should be noted that in situ hybridization of chromosomes with cloned BChE cDNA as probe suggested a homologous site on chromosome 16 [14] . This hybridization site might correspond to the Ez locus. However, the recent deter- To investigate the question of the multiplicity of BChE genes we decided to probe restriction length fragments of genomic DNA from individuals carrying the CS variant. For this purpose we prepared 4 32P-labeled genomic probes covering the 4 exons of the BChE gene and containing adjacent intronic sequences ( fig.1) . Southern blot analysis of hybridized DNA fragments indicates unambiguously that the DNA of individuals of Cf phenotype contains only one BChE gene.
MATERIALS AND METHODS

Blood samples
Blood samples were taken from the Lyon Blood Transfusion Center (CRTS de Lyon, 01704 Miribel, France). After venepuncture plasma was immediately separated from the blood cells for CS phenotyping. Blood bags of 450 ml from donors of phenotype C: were collected. Buffy coats were obtained from the blood bags according to the procedure of Cantell et al. [19] . After adding 5 ml of dimethylsulfoxide, buffy coat bags were stored at -20°C until DNA extraction.
CS phenoryping
CS was phenotyped by unidimensional polyacrylamide gel electrophoresis using the discontinuous buffer system of Juul [8] . We operated in a Hoefer vertical slab gel unit thermostated at 10°C. Gels were 1 mm thick and 6% acrylamide gels were used as separating gels. 3 ~1 plasma samples were loaded and electrophoreses were run for 3 h at constant current (25 mA/plate). After electrophoresis gels were stained for cholinesterase activity by the method of Karnovsky and Roots [20] with butyrylthiocholine iodide (1 mM) as the substrate.
DNA extraction from white blood cells
High molecular weight DNA was isolated from white blood cells by the classical phenol-chloroform procedure [21] The 4 BChE exon probes were "P-labeled by the random oligolabeling method of Feinberg and Vogelstein [22] . Labeling of probes was achieved in 6 h at room temperature; lo/r1 of [a-"P]dCTP (111 TBq/mmol) from Amersham and 2 units of labeling grade Klenow enzyme (Boehringer Mannheim) were used for each labeling (44-105 ng of probe in 100~1 of reaction medium). 3 . Hybridization of genomic blots with four "P-labeled exon probes. DNA was extracted from white blood cells of an individual of phenotype Cf. Blot 1 was hybridized with exon 1 probe; 2 with exon 2 probe; 3 with exon 3 probe; 4 with exon 4 probe.
Prehybridization of membranes was for 6 h at 61°C in 6 x SSC buffer (SSC is 0.15 M NaCl/O.OlS M sodium citrate, pH 7.0) containing 0.25% Carnation instant non-fat milk. Hybridization with 100 bl of each probe was performed for 20 h at 61°C in 25 ml of 6 x SSC/O.25% dry milk (probe concentration: 1.75 ng/ml for exon 1 probe; 4 ng/ml for the other probes). Then the blots were washed in 2 x SSC/O.l% sodium dodecylsulfate at 60°C (3 times, 1 h each). Autoradiographic exposures were for 3 days at 20°C with Kodak XAmong a population of 100 regular unrelated individuals were found blood donors, 6 to be of Cf phenotype ( fig.2) . In order to eliminate false positives, phenotyping was repeated several times over a period of 6 months. Three donors, named A, B and C, exhibited a high intensity CS band. Interestingly, the individual C suddenly turned as CS and became again Cs' two months later. This confirms previous observations of several investigators who noted that expression of CS is variable and non-mendelian [16, 23] . The individuals A, B and C were selected for DNA isolation from their white blood cells.
Omat films. Fig.3 are genomic blots of restriction fragments hybridized with the 4 32P-labeled BChE exon probes. As shown, radioactive bands range in size from 0.7 to 23 kb. For samples A, B and C, whatever the endonucleases used, the number and the size of these fragments are identical to those generated from genomic DNA from individuals in which the CS variant is not phenotypically expressed [ 181. These data are in agreement with the BChE gene structure as determined from restriction map of genomic clones [18] . In addition, direct sequencing of DNA after amplification by the polymerase chain reaction used for identification of BChE allelic variants never showed band heterogeneity that could mean the existence of a second BChE gene (124,251, La Du et al., submitted). All these results support the conclusion that only one BChE gene encodes the catalytic BChE subunits of CS as well as other BChE forms.
RESULTS AND DISCUSSION
Following the example of the human plasma CZ component [6] , CS has to be considered as a conjugate. The non-BChE protein still has to be identified. Work is in progress in this direction. So far it is certain that this protein is neither a degradation product of BChE nor acetylcholinesterase, nor albumin nor a collagenous tail fragment (P. Masson, unpublished results). The observed linkage between CHE2 and the y-crystallin gene cluster [ 161 does not imply that y-crystallin is conjugated with BChE subunits to form C5; but this hypothesis has still to be tested. We conclude that a second gene, previously called Ez, directs the production of the non-BChE component of CS and/or the enzymic system that controls the assembly of the BChE subunits with this protein.
